53 /100
HIGH RISK
Score updated Jul 14, 2026

PMN — ProMIS Neurosciences, Inc. Dilution Risk Tracker

Track PMN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PMN — Get alerts when the score changes →

As of July 14, 2026, ProMIS Neurosciences, Inc. (PMN) has a DilutionWatch DilutionScore of 53/100, rated HIGH dilution risk. ProMIS Neurosciences, Inc. has a market capitalization of $96.94M, 8.97M shares outstanding, 1 institutional holders tracked. Key dilution vectors include 174.7K outstanding warrants, approximately 25 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
10
📊 Float Risk
50
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
🔁 Convertible Conversion 15%
• Convertible debt present: 7.1% potential dilution
🔔 Track PMN — Get forecast alerts →

💹 Market Data

Market Cap$96.94M
Shares Outstanding8.97M
Float4.60M
Cash$63.85M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 100.0% shares (2025Q4 vs prior)
1 institutional holders · 1.7K shares
#1 BANK OF AMERICA CORP /DE/ 1.7K shares

📉 Short Interest

Short Interest203.9K
Days to Cover4.8
% of Float4.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Jun 30, 2022
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for PMN Shareholders

ProMIS Neurosciences, Inc. (PMN) has a DilutionScore of 53/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch tracks 174,673 outstanding warrants for PMN. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for PMN in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for PMN alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track PMN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PMN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for PMN
📊 PMN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PMN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.